Ezplaz can be used for life-threatening bleeds in 'austere' settings, agency says
— Ezplaz can be used for life-threatening bleeds in "austere" settings, agency says
July 29, 2026
• 2 min read
The FDA licensed Ezplaz, the first freeze-dried plasma product available to adults in need of transfusion, on Wednesday.
Ezplaz is intended for patients who need plasma -- such as those who are bleeding, need massive transfusion, or are bleeding while on warfarin -- when conventional frozen plasma is not available.
Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma
Military trauma experts say a newly approved plasma product could help expand lifesaving care far from hospitals.
The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat…
A World First: A Major Innovation in Blood Transfusion
U.S. FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell…
While not approved in Australia, the procedure is on the rise in the US. But there are questions of safety – and the ethics of…
Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma
XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next | CNN
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease - MannKind (NASDAQ:M
